|
HS Code |
749757 |
| Name | Daurisoline |
| Cas Number | 70553-76-3 |
| Molecular Formula | C21H27NO4 |
| Molecular Weight | 357.44 |
| Appearance | White to off-white powder |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Melting Point | 203-207°C |
| Iupac Name | (S)-2,3,9,10-Tetramethoxy-5,6,6a,7,8,12b-hexahydro-1H-isoquinolino[1,2-b]isoquinoline |
| Pubchem Cid | 359265 |
| Origin | Isolated from Menispermaceae plants (e.g., Menispermum dauricum) |
As an accredited Daurisoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Daurisoline, 10 mg: Supplied in an amber glass vial with a secure screw cap, labeled with product name, quantity, and CAS number. |
| Shipping | Daurisoline is shipped in tightly sealed containers, protected from light, moisture, and extreme temperatures. The chemical is handled in compliance with applicable regulations for safe transport, including appropriate labeling and documentation. Standard courier or specialized chemical shipping services may be used, ensuring safe, traceable, and prompt delivery to the destination. |
| Storage | Daurisoline should be stored in a tightly sealed container, away from moisture, light, and heat. Keep it in a cool, dry place, ideally at 2-8°C (refrigerated) unless otherwise specified by the manufacturer. Proper ventilation should be ensured, and access should be limited to trained personnel to prevent accidental exposure or degradation of the compound. |
Competitive Daurisoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
We’ve spent years in the lab isolating, purifying, and understanding the chemical properties of daurisoline. Sourced directly from Menispermum dauricum, daurisoline is a bisbenzylisoquinoline alkaloid that stands out due to its unique molecular structure. Years of hands-on extraction and refinement have given us perspective most product sheets leave out. Standard formulas focus on purity, but the real story involves how you achieve consistent isolation, how you tackle batch-to-batch differences, and what specifications matter most depending on the application.
We produce daurisoline under GMP-compliant conditions because even minor contaminants can alter its intended use. Typically, we carry daurisoline in powder form, targeting a purity of not less than 98 percent by HPLC. That’s where the numbers start, but the important bit is reproducibility. Purity matters little without reliable performance and process integration, so every batch undergoes full spectrum analysis, including mass spectrometry and NMR. By overseeing extraction and every purification step ourselves, we reduce operational risk for downstream users.
Unlike generic or off-the-shelf chemical suppliers, our process begins with direct sourcing of Menispermum dauricum rootstocks. No shortcuts, no brokered raw materials. This gives us tighter control over the bioactive profile, and it’s also how we guarantee that each kilogram has the same impurity fingerprint – details that become crucial for regulatory submissions or research reproducibility.
Most of our daurisoline clients come from pharmaceutical development and advanced medical research. Daurisoline has drawn research attention for its modulation of cardiac ion channels and potential anti-arrhythmic activity. Early findings—published in the Journal of Pharmacology and Experimental Therapeutics and similar outlets—link daurisoline to selective action on calcium and potassium channels, unlike many classical channel inhibitors. From our side, we accommodate requests for both single gram-scale packages suitable for early in vitro work, as well as kilogram-scale shipments for preclinical or scale-up studies.
Industrial-scale researchers and drug discovery teams require strict adherence to analytical standards. Unlike commodity traders, we deliver with full specification certificates, calibration against verified standards, and a log of every test run on that particular batch. This enables direct use in cardiac ion current assays, patch clamp studies, and more complex tissue-level evaluations. Research groups investigating anti-cancer or CNS-active properties appreciate the added layer of traceability—a feature rarely mentioned outside of regulated manufacturing circles.
A unique property of daurisoline is its dual action: it may block both delayed rectifier potassium current and L-type calcium channels. This duality gives pharmacologists the opportunity to study non-conventional anti-arrhythmic pathways. From a production standpoint, we constantly check for and remove close analogs like dauricine, which, if left unaddressed, may cloud your assay results or affect the pharmacological interpretation. Only with rigorous batch testing and process verification can we deliver consistently sound chemical samples.
One way to highlight the value of our daurisoline is to compare it with related bisbenzylisoquinoline alkaloids. Some research teams use dauricine or tetrandrine as near-substitutes, but our synthesis team has tracked how small differences in side-chain arrangements influence target receptor interaction. Take dauricine, for example: similar backbone, but different bioactivity and solubility. Tetrandrine shows broader activity, but its selectivity profile doesn’t match daurisoline, especially in cardiac studies. Relying on one as a substitute for another can derail entire research projects before statistically meaningful results emerge.
Production methods affect both physical characteristics and trace contaminants. A daurisoline batch missing rigorous purification—common in generic supply chains—often contains residual plant alkaloids or solvent traces. Such contamination can introduce confounding variables. From years of handling purification and scale-up ourselves, we can spot these issues not just on chromatograms but by changes in solubility or bioactivity in real use cases. Experience demonstrates that downstream failure rates increase when chemistry is left to chance.
Another feature often missed in market comparisons is batch-to-batch consistency. Many offshore operations assemble “spec-compliant” inventory using pooled stocks from unrelated sources, making cross-project data unreliable. As a manufacturer, we know a chromatographically identical daurisoline sample produced from different raw material batches will not always behave the same in complex biological matrices. Our production traceability eliminates this variability.
Purity claims mean little without documented proof. Every lot of daurisoline we supply carries a batch record showing date of manufacture, source of rootstock, and steps performed—down to extraction solvents and column conditions. Specifications are set by validated HPLC retention time, LC-MS spectrometry, melting point analyses, and moisture determination. If the sample doesn’t meet every documented threshold, it never enters the inventory pool for shipment. We insist on a consistently high standard, not because a certificate demands it, but because our customers’ entire research trajectory may depend on subtle differences from one batch to the next.
Our internal QC team performs regular reference checking against established international standards. Over time, these controls have picked up micro-impurities linked not just to source variation, but to atmospheric conditions during extraction and crystallization phases. Subtle contaminants might only show up after weeks in storage, or during sensitive in vivo studies. That’s why we also issue stability profiles with our shipments for long-term buyers, based on real thermal and humidity stress test data. This is the reality in practice—polished technical data sheets won’t tell you what happens twelve months after a batch leaves the warehouse.
Our approach hinges on transparency. Anyone who receives our daurisoline can request full lab notebooks for the lot they have on their bench. We’ve noticed that research groups appreciate quick access to solvent system details, or how trace impurity levels were characterized. This level of openness isn’t standard across the industry, but it helps scientists make informed decisions and speeds up regulatory package preparation.
Years of experience with bisbenzylisoquinoline alkaloids like daurisoline have led us to pay close attention to storage and handling requirements. Daurisoline in powder form requires airtight, light-protective storage at controlled ambient temperature. Moisture rapidly impacts both physical integrity and chemical activity. Our technical staff works with supply chain managers to engineer packaging solutions based on bulk order sizes—smaller vials for research, vacuum-sealed mylar pouches for industrial shipment.
Handling safety is another point not to ignore. Our on-site risk management group enforces protocols for staff handling, as inhalation or skin contact should be avoided. Lab personnel wear nitrile gloves, and all material transfer occurs in ventilated enclosures. This same attention to detail continues through logistics, where we ship only with carriers accredited for regulated chemical transport. Such precautions protect both customer and environment as product moves from us to your facility.
Complying with international pharma regulations is not a paperwork formality. Daurisoline may trigger country-specific reporting requirements. We monitor evolving compliance frameworks, ensuring every export has traceability data and certificates aligned to the importing region. Whether destined for university labs or preclinical pharma development, this approach reduces the burden on researchers when navigating customs inspections or preparing documentation for trials.
Our R&D team works directly with clients integrating daurisoline into a variety of pharmacological and cell biology workflows. For example, several of the cardiac electrophysiology groups we supply have built protocols centered on daurisoline’s impact on repolarization phase currents. In such protocols, batch-to-batch consistency proves critical—an inconsistent impurity load can shift IC50 curves or mute the desired effect entirely.
Some oncological research has explored daurisoline’s possible modulating effect on multidrug resistance proteins. Reliability of test data hinges on starting with pure product. Our experience has shown that even minor levels of plant-derived paralogs can skew cytotoxicity assay results, so we invested in advanced chromatographic isolation gear to keep our product free of such contaminants.
Research doesn’t end at the bench. Some of our clients follow through into animal model studies, where administration protocols depend on predictable solubility and formulation. To accommodate, we provide technical support regarding compatible co-solvents and vehicle systems. Having manufactured countless daurisoline batches to slightly varying hydration states, we’ve built up a practical knowledge bank to support these next-phase studies.
Feedback from research groups has taught us more than any technical guideline. For example, teams working on central nervous system pharmacology found that solvent choice and pH dramatically affect daurisoline’s behavior. We share formulation notes gathered from technical collaborations, which helps reduce setup time for new projects and increases the likelihood of transferable, publication-grade results.
Manufacturing daurisoline is nothing like trading it. Traders focus on price and availability, but rarely witness the micro-scale process difficulties that set the foundation for reliable biochemistry. When we launched our first pilot extraction, we faced yield swings from batch-to-batch due to subtle differences in rootstock maturity and drying conditions. Only by monitoring each batch—checking plant genetics, humidity, and even soil profile—did we stabilize the raw input. Today, this translates into more than just a spec sheet; it’s a commitment backed by hundreds of reproducible research samples.
Another distinction comes from in-house technical troubleshooting. Over the years, rare out-of-specification readings have led us to develop contingency protocols. Before any daurisoline leaves our dock, we’ve rebuilt processes, cross-checked analytical parameters, and re-trained staff to close the gap. Outside observers don’t see this continuous feedback loop. Our QC data is more than paperwork: it builds a safety net that allows researchers to put trust in our chemistry.
Long-term clients have told us their work gets easier when they know each shipment brings exactly the same material—down to the micron-sized crystal characteristics and buffer compatibility. These are lessons learned in scale-up, not on paper. As a manufacturer, we see firsthand how a single inconsistent batch can derail timelines or confound data analysis.
Sourcing daurisoline raw materials has always been a challenge. Over-harvesting of Menispermum dauricum threatens sustainability. By maintaining direct sourcing agreements and rotating collection zones, we avoid depletion and secure consistent supply without compromising plant populations. This isn’t just good practice; it’s essential if daurisoline research is to continue for years.
Another recurring issue is solvent residue. Instead of settling for routine atmospheric drying, we use vacuum-assisted drying under controlled inert gas. This reduces final moisture and prevents oxidation, which keeps functional group reactivity intact. In side-by-side tests, our product demonstrates longer shelf life and reduced degradation in storage.
Process upsets sometimes introduce batch variability. Years of running full-scale plant operations taught us that every process window must be documented and controlled. Staff receive technical training to spot deviations in real time and intervene before an issue can propagate. Detailed SOPs and digital batch tracking create a robust safety net for product consistency.
Research teams need flexibility, so we custom package daurisoline in bulk or smaller aliquots. Shipping always includes certificate of analysis, impurity spectrum, and suggested storage guidelines based on the destination climate. After years of working with both academic and industry clients, we know that accessibility and transparency make a real difference.
As manufacturers, our product stands apart from generic resellers and third-party aggregators. Because we handle everything in-house—from rootstock collection through packaging—we eliminate much of the variability that plagues distributed supply chains. Resellers often pool material from different harvest seasons, blurring traceability. Our system links every gram of daurisoline to a specific origin and production record.
Our ability to support custom synthesis requests also sets us apart. Some clients need isotopically labeled daurisoline, or derivatives tailored for binding studies. Having our own team of synthetic chemists and analytical experts makes rapid customization possible. This ensures that regardless of downstream project needs, our product fits research and regulatory standards without relying on unpredictable subcontractors.
Unlike products brokered for lowest cost, our batches pass rigorous testing for heavy metals, residual solvents, and biological activity. We never rely solely on supplier-supplied data. Full compliance with both global and local quality assurance frameworks keeps our material suitable for even the most demanding pharmaceutical development programs.
Daurisoline’s research future looks promising, with ongoing studies in cardiac, neurological, and oncology indications. As direct manufacturers, we keep a focused eye on shipment forecasting so that high-purity product remains available to the scientific community. Investment in expanded production lines now means even faster response times for urgent requests.
Collaborations with public and private research centers help us understand upcoming needs and refine our production planning. For researchers exploring novel indications or requiring unusual formulations, our development chemists provide technical backup and adapted production routes. A two-way dialogue means our product lineup evolves as the research landscape changes.
As regulatory scrutiny of research chemicals increases, buyers value direct-from-manufacturer traceability more than ever. Our established manufacturing history, combined with scientific partnerships, keeps us in tune with those demands. Every lot of daurisoline represents not only years of technical refinement but an ongoing commitment to the progress of medical and scientific discovery.
The true benefit of working with a direct manufacturer becomes clear outside of theory, in the real-world results achieved by our clients. Data integrity, repeatability, and actionable research findings all rest on chemical consistency. It’s easy to overlook the importance of ingredient sourcing until experimental outcomes fluctuate or regulatory submissions are delayed. We prevent these setbacks by investing at each stage of production and quality assurance.
Manufacturing daurisoline isn’t about volume alone. It’s an ongoing process of safeguarding quality and adapting to the nuanced requirements of highly specialized users. By focusing resources on upstream control, strict in-lab procedures, and technical support, we shorten the path between chemical supply and scientific breakthrough. We see the difference every day in the steady stream of publications, patents, and drug candidates built on solid chemical foundations.
Our commitment to making high-quality daurisoline available to researchers worldwide is rooted in decades of refinement and experience. Every shipment that leaves our facilities reflects attention to detail, technical insight, and an unwavering dedication to supporting the next wave of scientific innovation.